Study to Collect and Assess Long-term Safety of Everolimus in Patients Who Are on Everolimus Treatment in a Novartis-sponsored Study and Are Benefiting From the Treatment as Judged by the Investigator.
Clinical trial NCT02017860 · COMPLETED
Trial details
- NCT number
- NCT02017860
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-01-16
- Primary completion
- 2019-04-25
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.